102 related articles for article (PubMed ID: 5534494)
1. Effect of B.1912, a new riminophenazine derivative in murine leprosy.
Chang YT
Int J Lepr Other Mycobact Dis; 1970; 38(4):417-21. PubMed ID: 5534494
[No Abstract] [Full Text] [Related]
2. A study of skin pigmentation by clofazimine.
Levy L; Randall HP
Int J Lepr Other Mycobact Dis; 1970; 38(4):404-16. PubMed ID: 5534493
[No Abstract] [Full Text] [Related]
3. Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy.
Pettit JH; Rees RJ; Ridley DS
Int J Lepr Other Mycobact Dis; 1967; 35(1):25-33. PubMed ID: 5336368
[No Abstract] [Full Text] [Related]
4. [Action of B663 on obstinate reactogenic forms of Hansen's disease].
Rostant MM
Bord Med; 1970 Apr; 3(4):1033-4 passim. PubMed ID: 5422391
[No Abstract] [Full Text] [Related]
5. Chemotherapeutic trials in leprosy. 6. Pilot study of the riminophenazine derivative B.663 in low dosage (100 mgm. twice weekly) in the treatment of lepromatous leprosy.
Waters MF
Int J Lepr Other Mycobact Dis; 1968; 36(4):391-9. PubMed ID: 4898403
[No Abstract] [Full Text] [Related]
6. Histochemistry of B663 pigmentation: ceroid-like pigmentation in macrophages.
Sakurai I; Skinsnes OK
Int J Lepr Other Mycobact Dis; 1977; 45(4):343-54. PubMed ID: 75860
[TBL] [Abstract][Full Text] [Related]
7. B.663 (Geigy 30. 320) in the treatment of leprosy. A preliminary report.
Devadason C
Acta Trop; 1969; 26(3):265-9. PubMed ID: 4391239
[No Abstract] [Full Text] [Related]
8. Lipids in leprosy. 2. Histochemistry of lipids in human leprosy.
Sakurai I; Skinsnes OK
Int J Lepr Other Mycobact Dis; 1970; 38(4):389-403. PubMed ID: 4102020
[No Abstract] [Full Text] [Related]
9. [Activity of B663 in lepromatous leprosy. Therapeutic trial].
Pene P; Carrie J; Bourgeade A; Bolliot Y
Bull Soc Pathol Exot Filiales; 1971; 64(4):407-15. PubMed ID: 5172361
[No Abstract] [Full Text] [Related]
10. Clofazimine (Lamprene) in leprosy.
Drug Ther Bull; 1970 Jan; 8(2):7-8. PubMed ID: 4903794
[No Abstract] [Full Text] [Related]
11. B 663 (Lampren) in mycobacterial infections.
Pettit JH
Br J Dermatol; 1969 Oct; 81(10):794-5. PubMed ID: 5379868
[No Abstract] [Full Text] [Related]
12. Studies on sulfone resistance in leprosy. 2. Treatment with a riminophenazine derivative (B.663).
Pettit JH; Rees RJ
Int J Lepr Other Mycobact Dis; 1966; 34(4):391-7. PubMed ID: 6006070
[No Abstract] [Full Text] [Related]
13. Controlled drug trial of B.663 compared with DDS. Preliminary (48 week) report.
Tolentino JG; Rodriquez JN; Abalos RM
Int J Lepr Other Mycobact Dis; 1971; 39(3):738-41. PubMed ID: 5169924
[No Abstract] [Full Text] [Related]
14. [Trial of a new leprostatics (B-663) in the treatment of lepromatous leprosy].
Renders A
Ann Soc Belges Med Trop Parasitol Mycol; 1968; 48(6):625-35. PubMed ID: 5759964
[No Abstract] [Full Text] [Related]
15. B.663 and erythema nodosum leprosum.
Pettit JH
Int J Lepr Other Mycobact Dis; 1967; 35(3):401-2. PubMed ID: 5630363
[No Abstract] [Full Text] [Related]
16. Acute abdomen in a patient treated with lamprene.
Jagadeesan K; Visweswaran MK; Iyer KH
Int Surg; 1975 Apr; 60(4):208-9. PubMed ID: 1091577
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of B.663 in human leprosy.
Atkinson AJ; Sheagren JN; Rubio JB; Knight V
Int J Lepr Other Mycobact Dis; 1967; 35(2):119-27. PubMed ID: 5338956
[No Abstract] [Full Text] [Related]
18. Activity of phenazine analogs against Mycobacterium leprae infections in mice.
Van Landingham RM; Walker LL; O'Sullivan JF; Shinnick TM
Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):406-14. PubMed ID: 8228439
[TBL] [Abstract][Full Text] [Related]
19. [. 663 (G 30320 "Geigy"), a new chemotherapeutic agent against leprosy].
Vischer WA
Schweiz Med Wochenschr; 1967 Mar; 97(10):308. PubMed ID: 5585384
[No Abstract] [Full Text] [Related]
20. Treatment of leprosy with Lampren (B.663 Geigy).
De las Aguas JT
Int J Lepr Other Mycobact Dis; 1971; 39(2):493-503. PubMed ID: 4948089
[No Abstract] [Full Text] [Related]
[Next] [New Search]